Management of mild, primary Raynaud Syndrome: supplementation with Pycnogenol
Hu S, et al.
Published in Minerva Cardioangiologica
Key Findings
This pilot registry study suggests that Pycnogenol may be used with significant advantages in primary, mild RS. Subjects using Pycnogenol may control their symptoms and may avoid the need for more complex and, potentially dangerous or expensive treatments.
Conclusions
This pilot registry study suggests that Pycnogenol may be used with significant advantages in primary, mild RS. Subjects using Pycnogenol may control their symptoms and may avoid the need for more complex and, potentially dangerous or expensive treatments.
Supplements Studied
This pilot registry study suggests that Pycnogenol may be used with significant advantages in primary, mild RS. Subjects using Pycnogenol may control their symptoms and may avoid the need for more complex and, potentially dangerous or expensive treatments.
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.